MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 289 filers reported holding MYRIAD GENETICS INC in Q2 2014. The put-call ratio across all filers is 3.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $119,000 | -97.8% | 3,164 | -97.4% | 0.00% | -97.1% |
| Q4 2015 | $5,329,000 | -28.1% | 123,464 | -37.6% | 0.03% | -29.2% |
| Q3 2015 | $7,411,000 | -34.5% | 197,711 | -40.6% | 0.05% | -32.4% |
| Q2 2015 | $11,317,000 | -5.0% | 332,931 | -1.1% | 0.07% | -7.8% |
| Q1 2015 | $11,912,000 | +88.7% | 336,491 | +81.6% | 0.08% | +83.3% |
| Q4 2014 | $6,311,000 | -11.7% | 185,269 | 0.0% | 0.04% | -20.8% |
| Q3 2014 | $7,146,000 | +22.8% | 185,269 | +23.9% | 0.05% | +15.2% |
| Q2 2014 | $5,820,000 | – | 149,521 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |